Peter Paula Anton

US Patent:

20010053517, Dec 20, 2001

Filed:

Jun 24, 1999

Appl. No.:

09/344325

Inventors:

PETER A. ANTON - LOS ANGELES CA, US
IAN MCGOWEN - SAN FRANCISCO CA, US
IRVIN S.SY. CHEN - LOS ANGELES CA, US
JULIE E. ELLIOTT - SIGNAL HILL CA, US

International Classification:

C12Q001/68

US Classification:

435/006000

Abstract:

Provided are methods for determining the presence of a specific nucleic acid sequence in a non-fluid biological sample. Also provided are methods for detecting and determining the whole body viral burden of a virus in a subject.

US Patent:

20030138399, Jul 24, 2003

Filed:

May 12, 2000

Appl. No.:

09/569765

Inventors:

Peter Anton - Los Angeles CA, US
Janis Giorgi - Woodland Hills CA, US
Julie Elliott - Lory Beach CA, US
Michael Poles - Manhattan Beach CA, US

International Classification:

C12Q001/68
A61K045/00

US Classification:

424/085100, 435/006000

Abstract:

Provided are methods for inhibiting the progression of an inflammatory mediated mucosal infection. The methods include administering an effective amount of an anti-inflammatory agent. Also provided are compositions and articles of manufacture for preventing, and inhibiting the activation and progression of a mucosal infection.

US Patent:

55478441, Aug 20, 1996

Filed:

Feb 23, 1995

Appl. No.:

8/395495

Inventors:

Peter A. Anton - West Hollywood CA
Joseph R. Reeve - Oakhurst CA
John H. Walsh - Los Angeles CA
Kym F. Faull - Los Angeles CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 3353
C12N 100

US Classification:

435 71

Abstract:

Chemotactin, diethyl phthalate, is shown to be a chemoattractant secreted by H. pylori. Chemotactin attracts phagocytic cells with a resulting inflammatory episode. Chemotactin and its metabolites may be used for diagnosis and monitoring courses of infection by H. pylori or other chemotactin secreting organisms. In addition, chemotactin may be used in research for studying the inflammatory process, for identifying new drugs for modulating chemoattraction and activation of phagocytic cells, and for inducing an inflammatory response as a therapeutic intervention.

US Patent:

20210272118, Sep 2, 2021

Filed:

May 14, 2021

Appl. No.:

17/320900

Inventors:

- Cupertino CA, US
Oluwatomiwa B. ALABI - Studio City CA, US
Peter D. ANTON - San Francisco CA, US
Leonardo N. CANTELMO - San Francisco CA, US
George R. DICKER - Sunnyvale CA, US
Morgan GRAINGER - Nashville TN, US
Kevin LYNCH - Woodside CA, US
Nicholas J. SHEARER - London, GB
Simon TICKNER - Kent, GB

International Classification:

G06Q 20/40
G06Q 20/32
G06Q 20/10

Abstract:

The present disclosure generally relates to transaction user interfaces. In some examples, a user is notified if there is an error with transaction parameters and the device determines whether potentially compatible transaction parameters are available on the electronic device. In some examples, the user is notified if there is an error with transaction parameters and the user is prompted to use another device to enter new transaction information.

US Patent:

20200366742, Nov 19, 2020

Filed:

Aug 6, 2020

Appl. No.:

16/987003

Inventors:

- Cupertino CA, US
Oluwatomiwa B. ALABI - Studio City CA, US
Peter D. ANTON - San Francisco CA, US
George R. DICKER - Sunnyvale CA, US
Anton K. DIEDERICH - Mountain View CA, US
Donald W. PITSCHEL - San Francisco CA, US
Nicholas J. SHEARER - London, GB

International Classification:

H04L 29/08
H04L 29/06
G06F 21/10
G06F 21/35
G06Q 20/12
G06Q 20/32
G06Q 20/40
H04W 12/06

Abstract:

The present disclosure generally relates to techniques for managing a remote authorization to proceed with an action, such as creating a secure network connection. In some examples, a requesting device receives selection of one or more options. The requesting device transmits a request to proceed with an action to an authenticating device. The authenticating device concurrently displays an indication of the request to proceed with the action, information about the selected one or more options, and an indication of the requesting device. The authenticating device receives authorization to proceed with the action and transmits a response to the requesting device regarding the request to proceed with the action.